Not Yet RecruitingPhase 4

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

100 participantsStarted 2026-05

Plain-language summary

Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.

Who can participate

Age range1 Year – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed Iron Deficiency Anemia * Pediatric patients (1-18 years of age) without regard of gender, race, ethnicity nor language. * Able and willing to take oral iron (tablet or liquid). Exclusion Criteria: * Pregnant or lactating patients * Known allergies or intolerance to oral iron formulations * Concomitant chronic medical conditions affecting iron metabolism * Short gut syndrome * Celiac disease * Inflammatory bowel disease * Cancer * Chronic kidney disease * Blood transfusions in the past 3 months * IV iron administration in the past 3 months * Oral iron supplementation in the past 2 weeks

What they're measuring

Hemoglobin stabilization

Timeframe: Change between baseline and 3 months post-enrollment

Serum Ferritin stabilization

Timeframe: Change between baseline and 3 months post-enrollment

Trial details

NCT IDNCT06550362

SponsorLoma Linda University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

Contact for this trial

Albert Kheradpour, MD

909.651.1910 akheradp@llu.edu

View on ClinicalTrials.gov More Iron Deficiency Anemia trials